AllSquare Wealth Management’s Nektar Therapeutics NKTR Stock Holding History

AllSquare Wealth Management’s Portfolio NKTR Stock Details NKTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$1.02K	Hold	18	–	–	﹤0.01%	483
2025 Q2	$465	Hold	18	–	–	﹤0.01%	506
2025 Q1	$188	Hold	18	–	–	﹤0.01%	516
2024 Q4	$258	Hold	18	–	–	﹤0.01%	513
2024 Q3	$360	Hold	18	–	–	﹤0.01%	512
2024 Q2	$343	Hold	18	–	–	﹤0.01%	507
2024 Q1	$259	Hold	18	–	–	﹤0.01%	509
2023 Q4	$157	Hold	18	–	–	﹤0.01%	515
2023 Q3	$165	Hold	18	–	–	﹤0.01%	523
2023 Q2	$173	Hold	18	–	–	﹤0.01%	541
2023 Q1	$195	Hold	18	–	–	﹤0.01%	532
2022 Q4	$626	Hold	18	–	–	﹤0.01%	489
2022 Q3	$1K	Hold	18	–	–	﹤0.01%	483
2022 Q2	$1K	Hold	18	–	–	﹤0.01%	487
2022 Q1	$1K	Hold	18	–	–	﹤0.01%	489
2021 Q4	$4K	Hold	18	–	–	﹤0.01%	433
2021 Q3	$5K	Hold	18	–	–	﹤0.01%	410
2021 Q2	$5K	Hold	18	–	–	﹤0.01%	426
2021 Q1	$6K	Hold	18	–	–	﹤0.01%	409
2020 Q4	$5K	Hold	18	–	–	﹤0.01%	387
2020 Q3	$5K	Hold	18	–	–	﹤0.01%	385
2020 Q2	$6K	Hold	18	–	–	﹤0.01%	379
2020 Q1	$5K	Hold	18	–	–	﹤0.01%	364
2019 Q4	$6K	Hold	18	–	–	﹤0.01%	367
2019 Q3	$5K	Hold	18	–	–	﹤0.01%	378
2019 Q2	$10K	Hold	18	–	–	0.01%	336
2019 Q1	$9K	Buy	+18	New	+$10.7K	0.01%	343
2018 Q4	–	Sell	-67	Closed	-$61K	–	474
2018 Q3	$61K	Buy	67 +60	+857%	+$51.2K	0.05%	162
2018 Q2	$5K	Buy	+7	New	+$8.07K	﹤0.01%	403

Other funds holding NKTR

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

AllSquare Wealth Management's NKTR Position: Q3 2025 in Review

AllSquare Wealth Management held its Nektar Therapeutics (NKTR) position steady in Q3 2025 at 18 shares worth $1.02K. The position accounts for ﹤0.01% of the portfolio, ranked #483.

AllSquare Wealth Management first reported a position in NKTR in Q2 2018 and has held it in 29 quarters since. The position peaked at $61K in Q3 2018. 154 funds tracked by Wall St. Rank hold NKTR as of Q3 2025.

AllSquare Wealth Management held 18 shares of Nektar Therapeutics worth $1.02K as of Q3 2025.
AllSquare Wealth Management left its Nektar Therapeutics share count unchanged in Q3 2025.
Nektar Therapeutics made up ﹤0.01% of AllSquare Wealth Management's portfolio in Q3 2025, its #483 holding.
AllSquare Wealth Management first reported a position in Nektar Therapeutics in Q2 2018 and has held it in 29 quarters since.
AllSquare Wealth Management's Nektar Therapeutics position peaked at $61K in Q3 2018.
154 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2025.

Based on AllSquare Wealth Management's 13F filing for Q3 2025, filed 12 Jan 2026.